Surveillance of adverse events following immunisation in Australia, 2023 Submitted by Jackson.young on Tue, 21/10/2025 This report summarises Australia’s spontaneous surveillance data for adverse events following immunisation (AEFI) for all vaccines administered in 2023, reported to the Therapeutic Goods Administration (TGA). This report combines COVID and non-COVID AEFI that were previously reported separately in 2022 and 2021. Read more about Surveillance of adverse events following immunisation in Australia, 20232 views
Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 2022 Submitted by Jackson.young on Fri, 19/09/2025 The Therapeutic Goods Administration monitors the safety of vaccines in Australia by collecting and reviewing spontaneous reports of adverse events following immunisation. This report describes the data collected through this spontaneous surveillance system in 2022 for all vaccines other than COVID-19 vaccines. Read more about Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 20224 views
Reduction in self-reported adverse events in Australian adults after change to national immunisation schedule from polysaccharide to conjugate pneumococcal vaccine, 2016-2022 Read more about Reduction in self-reported adverse events in Australian adults after change to national immunisation schedule from polysaccharide to conjugate pneumococcal vaccine, 2016-20223 views
Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: a multinational self-controlled case series study Read more about Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: a multinational self-controlled case series study4 views
Surveillance of adverse events following immunisation in Australia, 2022 Submitted by scott.mair@hea… on Thu, 08/05/2025 The Therapeutic Goods Administration monitors the safety of vaccines in Australia by collecting and reviewing spontaneous reports of adverse events following immunisation. This report describes the data collected through this spontaneous surveillance system in 2022 for all vaccines other than COVID-19 vaccines. Read more about Surveillance of adverse events following immunisation in Australia, 202226 views
Antecedent and persistent symptoms in COVID-19 and other respiratory illnesses: insights from prospectively collected data in the BRACE trial Read more about Antecedent and persistent symptoms in COVID-19 and other respiratory illnesses: insights from prospectively collected data in the BRACE trial13 views
Short-term active safety surveillance of the Spikevax and Nuvaxovid priming doses in Australia Read more about Short-term active safety surveillance of the Spikevax and Nuvaxovid priming doses in Australia12 views
Safety of four COVID-19 vaccines across primary doses 1, 2, 3 and booster: a prospective cohort study of Australian community pharmacy vaccinations Read more about Safety of four COVID-19 vaccines across primary doses 1, 2, 3 and booster: a prospective cohort study of Australian community pharmacy vaccinations10 views
Accelerated Bacille Calmette-Guérin reactions: more than meets the eye Read more about Accelerated Bacille Calmette-Guérin reactions: more than meets the eye22 views
Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 2021 Read more about Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 202124 views
